THY-1 Cell Surface Protein and Human Cytomegalovirus Infection by Peters, Carson et al.
111  THY-1 Cell Surface Protein and Human Cytomegalovirus Infection 
Peters , Li, and Cohen 
 
 
Journal of Health Disparities Research and Practice Volume 9, Special Edition 1, 2016 
The pursuit of Young Researchers: NIDDK STEP-UP  
 http://digitalscholarship.unlv.edu/jhdrp/    
Journal of Health Disparities Research and Practice 
Volume 9, Special Edition 1, Summer 2016, pp. 111 
© 2011 Center for Health Disparities Research 
School of Community Health Sciences 
University of Nevada, Las Vegas 
  
 
THY-1 Cell Surface Protein and Human Cytomegalovirus Infection 
Carson Peters   
Dr. Qingxue Li, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious 
Diseases (NIAID) 
Dr. Jeffrey Cohen, Laboratory of Infectious Diseases, National Institute of Allergy and 
Infectious Diseases (NIAID) 
Coordinating Center: Stanford University 
 
 
ABSTRACT 
 This research project is to investigate the role of a cell surface protein, THY-1, as an entry 
mediator for Human Cytomegalovirus (HCMV) infection. Previous research suggested that 
HCMV attaches to THY-1 on the host cell surface through virus encoded glycoprotein gB. The 
glycoproteins are located on the surface of virus particles thus initiating entry and infection. The 
specific question is to determine if the presence of a soluble form of THY-1 protein (sTHY-1) 
during the onset of infection would impair HCMV infectivity, based on the hypothesis that 
sTHY-1 would interrupt the interaction between the infectious virion and the target cells by 
competing with authentic cell surface THY-1 for binding to gB.  
 The experimental approach is to prepare a plasmid encoding sTHY-1, to introduce it into 
mammalian cells by transfection to express the protein, to purify the sTHY-1, and to test the 
purified protein using Western blot and blocking of infection assays.  
 HCMV is a herpes virus transmitted through saliva, urine, or other body fluids. Congenital 
HCMV occurs when HCMV is passed from a pregnant mother to her fetus. Many people 
encounter HCMV in their lifetime and according to the Centers for Disease Control (CDC), 50 to 
80 percent of adults who are 40 or older are infected with HCMV. For individuals with a healthy 
immune system, HCMV produces mild illness, and for immunocompromised individuals, 
HCMV has a high rate of reactivation and can cause serious disease. 
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